by Eric Christianson | Sep 11, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Opvee (nalmefene), is an intranasal opioid antagonist used for opioid overdose and was approved by the FDA in 2023. This approval provided another tool to aid in combating the opioid crisis. There are currently two medications, Opvee and Narcan (naloxone), that can...
by Eric Christianson | Sep 8, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
In this blog post, I want to share some important SSRI clinical pearls that help clinicians decide which of these antidepressants to use. Note that these clinical practice pearls are good examples of some testable items that may show up on your board exam 🙂 Sertraline...
by Eric Christianson | Sep 4, 2024 | Psychiatry and Addiction Medicine Case Studies
JS is a 58-year-old female who has taken tramadol (podcast) for years due to chronic back pain. She has been experiencing worsening symptoms of depression and has been tried on duloxetine and sertraline in the past. Both of these medications caused GI upset and she is...
by Eric Christianson | Sep 1, 2024 | Gastrointestinal Case Studies
A 76-year-old male has a past medical history of hypertension, diarrhea, mild cognitive impairment, diabetes, osteoarthritis, and gout. He has had a concern that has been ongoing for about 3 months with the symptoms recently escalating over the last 1-2 weeks....
by Eric Christianson | Aug 28, 2024 | Cardiovascular Medication and Disease State Clinical Pearls
Rivaroxaban is classified as a direct oral anticoagulant. It is one of the most commonly used anticoagulants within this class (in addition to apixaban). In this blog post, I’ll share the 5 most important rivaroxaban clinical pearls that may appear in practice...
